The University of Central Lancashire’s Addison Awards scheme provides opportunities to gain both financial support and essential teaching experience while pursuing a full-time programme for PhD. The awards are tenable for up to 3 years with an expected commencement date of 1 October 2008. The stipend is £12,940 per annum and the award covers the cost of tuition fees at UK/EU rates (International students may apply but will need to fund the difference between the fees rates). Award holders will be expected to contribute up to 6 hours teaching per week.
Applicants should have, or expect to receive, an upper second class or first class honours degree or an MSc in a related discipline.
Nanotechnologies
Design and development of proliposome nanotechnologies for intranasal vaccination
Particulate-based and solvent-based proliposome vaccine nanotechnologies will be developed for intranasal administration using nasal sprays
Reference No RS/07/21
Informal enquiries (project related) may be directed to Dr Abdelbary Elhissi (+44 (0)1772 895807, or email aelhissi@uclan.ac.uk)
Requests for an application pack (quoting the reference number RS/07/21) should be directed to the Graduate Research Office. Tel +44 (0)1772 894287 or e-mail researchdegrees@uclan.ac.uk
Closing Date: 30 June 2008
The University of Central Lancashire’s Addison Awards scheme provides opportunities to gain both financial support and essential teaching experience while pursuing a full-time programme for PhD. The awards are tenable for up to 3 years with an expected commencement date of 1 October 2008. The stipend is £12,940 per annum and the award covers the cost of tuition fees at UK/EU rates (International students may apply but will need to fund the difference between the fees rates). Award holders will be expected to contribute up to 6 hours teaching per week.
Applicants should have, or expect to receive, an upper second class or first class honours degree or an MSc in a related discipline.
GABA regulation
The regulation of GABA mediated inhibition of glutamate release in chronic pain. Utilising a multidisciplined approach (in vivo behavioural studies, in vivo and in vitro release studies and cellular/histological applications), the function of proteins regulating extracellular levels of the inhibitory neurotransmitter GABA in the CNS will be investigated. Changes in this control of GABA within the spinal cord may contribute to abnormal sensory processing manifest in conditions of chronic neuropathic pain.
Reference No RS/07/26
Informal enquiries (project related) may be directed to Dr Christopher Smith (+44 (0)1772 895845, or email cgssmith@uclan.ac.uk)
Requests for an application pack (quoting the reference number RS/07/26) should be directed to the Graduate Research Office. Tel +44 (0)1772 894287 or e-mail researchdegrees@uclan.ac.uk
Closing Date: 30 June 2008